Corrigendum to ‘Immunogenicity and safety of Biological E’s CORBEVAX™ vaccine as a heterologous booster dose in adult volunteers previously vaccinated with two doses of either COVISHIELD™ or COVAXIN: A Prospective double-blind randomised phase III clinical study’ [IJID Regions, volume 17 (2025) 100786]

IJID Regions 2026 Open access

Read full text
Authors: Subhash Thuluva, Vikram M. Paradkar, SubbaReddy Gunneri, Vijay Yerroju, Rammohan Reddy Mogulla, Kamal Thammireddy, Siddalingaiah Ningaiah, Chirag Dhar, Akshay Binayke, Aymaan Zaheer, Amit Awasthi, Shiva Narang
+3 more Naveen Chander Reddy, Anil Kumar Pandey, Chitta Sitaram Anjaneylu
DOI: 10.1016/j.ijregi.2025.100831
Cited by: 0

Abstract

[This corrects the article DOI: 10.1016/j.ijregi.2025.100786.].

Fields of Study & Subjects

SARS-CoV-2 and COVID-19 Research Heparin-Induced Thrombocytopenia and Thrombosis Intramuscular injections and effects

Publication details

Journal / source
IJID Regions
Volume
18
Pages
100831–100831
Publication date
2 January 2026
Language
EN